The Impact of Psychedelics on Neural Circuits, Learning and Memory, and Psychiatric Dysfunction

The Impact of Psychedelics on Neural Circuits, Learning and Memory, and Psychiatric Dysfunction

Psychedelics are showing promising results in the treatment of various psychiatric disorders including depression, anxiety, posttraumatic stress disorder, obsessive compulsive disorder, and addiction. However, the mechanisms by which 1-3 doses can have persisting effects across several disorders remains to be understood. 

This webinar will focus on what is known about how psychedelics impact brain function and recent work from our group highlighting unique effects of psychedelics on different learning and memory processes that may speak to their therapeutic efficacy (but also potential negative effects). 

The webinar will also touch on the state of the clinical research on psychedelics including the recent passing of Senate Bill 2308 in Texas that will allocate $50 million for research on the atypical psychedelic ibogaine, which appears to have particularly noteworthy efficacy in the treatment of opioid use disorder.

Learn more & register

For trainings that indicate Continuing Education Units (CEUs) are available, contact the organizer and/or the Vermont Office of Professional Regulation to verify that the credits will count toward the continuing education requirements of your licensure or certification.